|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.8950 EUR | +5.17% |
|
+0.56% | -41.73% |
| 06-18 | AB Science Secures US Patent for Prostate Cancer Therapy | MT |
| 06-18 | AB Science Secures New U.S. Patent for Masitinib |  |
Sales 2024 by Business Segment
Sales 2024 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Pharmaceutical Products | ||||||||||
Pharmaceuticals | 1.58M | 1.61M | 958K | 970K | 1.07M | |||||
Total Assets | 29.69M | 21.27M | 23.84M | 25.5M | 23.18M | |||||
Interest Expense | -117K | -23K | -823K | -1.53M | -1.12M | |||||
Income Tax Expense | 8K | 36K | 4K | - | - | |||||
CAPEX | -370K | -564K | -644K | -345K | -155K | |||||
EBT | -15.04M | -14.43M | -13.61M | -11.98M | -7.83M | |||||
D&A | 1.09M | 886K | 805K | 990K | 671K | |||||
Operating Income | -14.75M | -13.81M | -15.94M | -13.43M | -6.08M | |||||
Net Income | -15.04M | -14.46M | -13.62M | -11.98M | -7.83M |
Geographical Revenue Distribution History
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
- Stock Market
- Stocks
- AB Stock
- Financials AB Science
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
